Search

Your search keyword '"Aarstad HJ"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Aarstad HJ" Remove constraint Author: "Aarstad HJ"
109 results on '"Aarstad HJ"'

Search Results

1. Distinct subpopulations of cancer associated fibroblasts in oral squamous cell carcinoma revealed by imaging mass cytometry.

4. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.

5. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: A prospective cohort study.

6. Periodontitis and dental quality of life predict long-term survival in head and neck cancer.

7. Hearing, Balance, and Mortality: Sex-Specific Patterns in a Longitudinal Study.

8. Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue microenvironment in formalin-fixed archival clinical tissues.

9. Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival.

10. The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(-) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients.

11. Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma Patients.

12. The Romberg sign, unilateral vestibulopathy, cerebrovascular risk factors, and long-term mortality in dizzy patients.

13. Psychometric properties for the Norwegian translations of two revised APHAB-subscales and an adapted IOI-HA (IOI-CI) in patients with cochlear implants.

14. Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma.

15. Psychometric properties of the Norwegian translation of the Tinnitus Handicap Inventory (THI-NOR).

17. Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters.

18. The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma.

19. Importance of personality and coping expectancy on patient-reported hearing disability, quality of life and distress level: a study of patients referred to an audiology service.

20. Long-Term Survival in 1,931 Patients With Dizziness: Disease- and Symptom-Specific Mortality.

21. Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC).

22. Reduced grey- and white matter volumes due to unilateral hearing loss following treatment for vestibular schwannoma.

23. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles.

24. Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery.

25. Evaluation of Self-reported Symptoms in 1,457 Dizzy Patients and Associations With Caloric Testing and Posturography.

26. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.

27. Acoustic Voice Analysis and Maximum Phonation Time in Relation to Voice Handicap Index Score and Larynx Disease.

28. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.

29. Quality of life in persons with hearing loss: a study of patients referred to an audiological service.

30. Hearing as an Independent Predictor of Postural Balance in 1075 Patients Evaluated for Dizziness.

31. Periodontal status at diagnosis predicts non-disease-specific survival in a geographically defined cohort of patients with oropharynx squamous cell carcinoma.

32. An fMRI-study on single-sided deafness: Spectral-temporal properties and side of stimulation modulates hemispheric dominance.

33. Correlation between Excessive Daytime Sleepiness (EDS) and self-reported and objective nasal characteristics.

34. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients.

35. Generic quality of life in persons with hearing loss: a systematic literature review.

36. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.

37. Clinical Application and Psychometric Properties of a Norwegian Questionnaire for the Self-Assessment of Communication in Quiet and Adverse Conditions Using Two Revised APHAB Subscales.

38. Health-related Quality of Life as Studied by EORTC QLQ and Voice Handicap Index Among Various Patients With Laryngeal Disease.

39. In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.

40. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.

41. Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.

42. Congenital laryngomalacia is related to exercise-induced laryngeal obstruction in adolescence.

43. Functional-structural reorganisation of the neuronal network for auditory perception in subjects with unilateral hearing loss: Review of neuroimaging studies.

44. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.

45. The Norwegian Voice Handicap Index (VHI-N) patient scores are dependent on voice-related disease group.

46. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.

47. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.

48. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.

49. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients.

50. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

Catalog

Books, media, physical & digital resources